Facial and hand allotransplantation

Abstract

Vascularized composite allotransplantation (VCA) is a novel therapeutic option for treatment of patients suffering from limb loss or severe facial disfigurement. To date, 72 hand and 19 facial transplantations have been performed worldwide. VCA in hand and facial transplantation is a complex procedure requiring a multidisciplinary team approach and extensive surgical planning. Despite good functional outcome, courses after hand and facial transplantation have been complicated by skin rejection. Long-term immunosuppression remains a necessity in VCA for allograft survival. Towiden the scope of these quality-of-life-improving procedures, minimization of immunosuppression to limit risks and side effects is needed. © 2014 Cold Spring Harbor Laboratory Press. all rights reserved.